相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stroke in COVID-19: A systematic review and meta-analysis
Stefania Nannoni et al.
INTERNATIONAL JOURNAL OF STROKE (2021)
Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?
Borkwei Ed Nignpense et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women
Robyn L. Woods et al.
CIRCULATION (2020)
The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
Bruce D. Hammock et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke
Malgorzata Szczuko et al.
SCIENTIFIC REPORTS (2020)
Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis
Mai Yamakawa et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
William A. E. Parker et al.
PLATELETS (2019)
IL-17-high asthma with features of a psoriasis immunophenotype
Joergen Oestling et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Measurement of Thromboxane Biosynthesis in Health and Disease
Carlo Patrono et al.
FRONTIERS IN PHARMACOLOGY (2019)
Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury
Yukihito Nakano et al.
HYPERTENSION RESEARCH (2019)
Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours
Cati Racca et al.
PLATELETS (2019)
Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future
Harron Khan et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A2 Pathway
Wenzhe Wang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population
Lei Li et al.
NEURAL REGENERATION RESEARCH (2018)
Drawing a link between the thromboxane A2 pathway and the role of platelets and tumor cells in ovarian cancer
Karolina Serhan et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
Paola Simeone et al.
NUTRIENTS (2018)
Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
Stephen B. Hladky et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
The definition of stroke
Alexander P. Coupland et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2017)
Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients
Xingyang Yi et al.
PLOS ONE (2017)
Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells
Zhihong Zhao et al.
ONCOTARGET (2017)
Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis
Katherine L. Tucker et al.
PLOS MEDICINE (2017)
Genetic Signatures in Ischemic Stroke: Focus on Aspirin Resistance
Kanika Vasudeva et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Inflammation in acute CNS injury: a focus on the role of substance P
F. Corrigan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis
Vivan J. M. Baggen et al.
EUROPEAN RADIOLOGY (2016)
Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis
Kevin P. Bliden et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2016)
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury
Aijuan Yan et al.
SCIENTIFIC REPORTS (2016)
Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
Wojciech Szczeklik et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Gadolinium Enhancement in Intracranial Atherosclerotic Plaque and Ischemic Stroke: A Systematic Review and Meta-Analysis
Ajay Gupta et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events
Kevin P. Bliden et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
Demyelination as a rational therapeutic target for ischemic or traumatic brain injury
Hong Shi et al.
EXPERIMENTAL NEUROLOGY (2015)
G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity
Matthias R. Meyer et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension
David Sacerdoti et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Platelet function tests: a comparative review
Rita Paniccia et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
The epidemiology of silent brain infarction: a systematic review of population-based cohorts
Jonathon P. Fanning et al.
BMC MEDICINE (2014)
Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel
Plino Cunha Sathler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A2 Production
Mei-Chi Chang et al.
PLOS ONE (2014)
Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair
Chengrui An et al.
PROGRESS IN NEUROBIOLOGY (2014)
Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of these guidelines as an educational tool for neurologists
James F. Meschia et al.
STROKE (2014)
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease
Luis R. Lopez et al.
WORLD JOURNAL OF DIABETES (2014)
Aspirin nonresponders in patients with ischaemic stroke
Pornpatr A. Dharmasaroja et al.
BLOOD COAGULATION & FIBRINOLYSIS (2013)
Association of thromboxane A2 receptor gene polymorphisms with cerebral infarction in a Chinese population
Jing Zhao et al.
NEUROLOGICAL SCIENCES (2013)
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Valerie Capra et al.
MEDICINAL RESEARCH REVIEWS (2013)
Antiplatelet Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John W. Eikelboom et al.
CHEST (2012)
Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e637S, 2012)
Per Olav Vandvik
CHEST (2012)
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
Isabella Russo et al.
DIABETES (2012)
Short- and Long-Term Blood Pressure Variability Present and Future
Giuseppe Mancia
HYPERTENSION (2012)
Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials
Jing Zhang et al.
NEUROLOGICAL RESEARCH (2012)
Managing patients with multimorbidity: systematic review of interventions in primary care and community settings
Susan M. Smith et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Primary and Secondary Prevention of Cardiovascular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Olav Vandvik et al.
CHEST (2012)
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation
Steven D. Douglas et al.
YEAR IN IMMUNOLOGY (2011)
Thromboxane and the thromboxane receptor in cardiovascular disease
Emer M. Smyth
CLINICAL LIPIDOLOGY (2010)
The role of weight and enteric coating on aspirin response in cardiovascular patients
A. Peace et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Cardiovascular events associated with the use of four nonselective NSAIDs (Etodolac, Nabumetone, Ibuprofen, or Naproxen) versus a cyclooxygenase-2 inhibitor (Celecoxib): A population-based analysis in Taiwanese adults
Weng-Foung Huang et al.
CLINICAL THERAPEUTICS (2006)
Cyclooxygenases, thromboxane, and atherosclerosis -: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism
KM Egan et al.
CIRCULATION (2005)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
分享论文
